Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F3PNQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,433
Award facts
- Contract value 100% obligated
- $11,433.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,433.07 for DESCOVY 200-25 mg tablets (30-count units) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical federal medical procurement vendor, particularly for the Defense Health Agency and military healthcare systems. The company's portfolio demonstrates extensive capability across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has consistently met federal procurement requirements through competitive awards, positioning it as a key supplier within the Defense Logistics Agency's medical supply chain infrastructure. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, which may expand the company's role in supporting federal healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F3PNQ?
SPE2DR26F3PNQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F3PNQ worth?
The government has obligated $11,433 on SPE2DR26F3PNQ.
Is contract SPE2DR26F3PNQ an order under another contract?
Yes. SPE2DR26F3PNQ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3PNQ competed?
The extent of competition for SPE2DR26F3PNQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award